Can the virus infection of human immunodeficiency virus (HIV) be prevented? This is the question which answer will be searched by the Center for Virology and Biotechnology, Vector, in Russia. The state-funded research center is trying to create a vaccine that can induce strong antibody (antigen).
“We have successfully completed the first phase of clinical trials of HIV vaccines,” said the head of Vector, Alexander Sergeyev. The vaccine is now awaiting approval to test the second stage.
Vector had previously said that they had developed one of the strongest and most advanced vaccine in the world. If the test phase is completed and successful, it will be a new hope for people living with HIV / AIDS which cure has not been found yet.
On 1 November, Russia had 636,979 HIV cases which were confirmed since records began in 1987. The amount is almost doubled since 2006. A total of 104,257 HIV patients have died.
HIV (human immunodeficiency virus) infects cells of the immune system and destroys or impairs their function. This viral infection causes progressive damage of the immune system, undermining the body’s ability to fend off infection and disease. AIDS (Acquired Immune Deficiency Syndrome) refers to the further stages of HIV infection.
According to the World Health Organization (WHO), the number of people living with HIV worldwide continues to grow until it reaches 33,.3 million people in 2009 with 2.6 million new infections and 1.8 million lives taken away by this virus.
HIV / AIDS remains one of the most significant challenges in the world, especially in low and middle income countries. About 10 million people worldwide are infected with HIV do not have access to adequate health care.Tagged with: Aids, Hiv, HIV vaccine, HIV vaccine Russia,